Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Last Updated: May 29, 2023

CLINICAL TRIALS PROFILE FOR TROGLITAZONE

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

All Clinical Trials for Troglitazone

Subscribe to access the full database, or Try a Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00003058 ↗	Troglitazone in Treating Patients With Liposarcoma	Completed	National Cancer Institute (NCI)	Phase 2	1997-06-01	Troglitazone may help liposarcoma cells develop into normal cells. This was a single arm, open-label study with a two-stage design to evaluate troglitazone in patients with liposarcoma stratified by histologic subtype.
NCT00003058 ↗	Troglitazone in Treating Patients With Liposarcoma	Completed	Dana-Farber Cancer Institute	Phase 2	1997-06-01	Troglitazone may help liposarcoma cells develop into normal cells. This was a single arm, open-label study with a two-stage design to evaluate troglitazone in patients with liposarcoma stratified by histologic subtype.
NCT00116545 ↗	TART - Troglitazone Atherosclerosis Regression Trial	Completed	Parke-Davis	Phase 2/Phase 3	1997-01-01	The purpose of this study is to determine if troglitazone reduces the progression of early preintrusive carotid atherosclerosis in insulin-requiring diabetes patients.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for Troglitazone

Condition Name

Chart
Table

Condition Name for Troglitazone
Intervention	Trials
Diabetes Mellitus, Type 2	4
Impaired Glucose Tolerance	2
Type 2 Diabetes Mellitus	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for Troglitazone
Intervention	Trials
Diabetes Mellitus	9
Diabetes Mellitus, Type 2	8
Glucose Intolerance	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Troglitazone

Trials by Country

Map
Table

Trials by Country for Troglitazone
Location	Trials
United States	12
Italy	7
India	7
Canada	6
Mexico	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for Troglitazone
Location	Trials
California	3
Texas	2
Utah	1
Pennsylvania	1
North Dakota	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Troglitazone

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for Troglitazone
Clinical Trial Phase	Trials
Phase 4	3
Phase 3	3
Phase 2/Phase 3	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for Troglitazone
Clinical Trial Phase	Trials
Completed	14
Terminated	1
Unknown status	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Troglitazone

Sponsor Name

Chart
Table

Sponsor Name for Troglitazone
Sponsor	Trials
Canadian Institutes of Health Research (CIHR)	3
Drug Safety and Effectiveness Network, Canada	3
Canadian Network for Observational Drug Effect Studies, CNODES	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for Troglitazone
Sponsor	Trials
Other	21
Industry	8
U.S. Fed	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt

Johnson and Johnson

Medtronic

Colorcon

Express Scripts

McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.